These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6867699)
41. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647 [TBL] [Abstract][Full Text] [Related]
42. Chlorthalidone-triamterene: a potassium-sparing diuretic combination for the treatment of oedema. Webb EL; Godfrey JC; Rosenbaum R; Zisblatt M; Vukovich RA; Neiss ES J Int Med Res; 1984; 12(3):147-53. PubMed ID: 6376209 [TBL] [Abstract][Full Text] [Related]
43. Combined clonidine-chlorthalidone therapy in hypertension. Two years' experience in 30 patients. Rosenman RH Arch Intern Med; 1975 Sep; 135(9):1236-9. PubMed ID: 1164125 [TBL] [Abstract][Full Text] [Related]
44. An evaluation of the effect on resting and exercise blood pressure of some first line treatments in hypertension. Lorimer AR; Barbour MB; Lawrie TD Ann Clin Res; 1983; 15(1):30-4. PubMed ID: 6859790 [TBL] [Abstract][Full Text] [Related]
45. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension. Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934 [TBL] [Abstract][Full Text] [Related]
46. Total body and serum potassium during treatment with atenolol in combination with chlorthalidone. Gotzen R; Hiemstra S J Int Med Res; 1981; 9(4):292-4. PubMed ID: 7262453 [No Abstract] [Full Text] [Related]
47. Metabolic effects of long-term therapy with muzolimine and chlorthalidone in hypertension. Galletti F; Strazzullo P; Gagliardi R; Cirillo M; Siani A; Iacone R; Mancini M Eur J Clin Pharmacol; 1987; 33(5):515-7. PubMed ID: 3428346 [TBL] [Abstract][Full Text] [Related]
48. [Controlled study of the antihypertensive effects of the combination of metoprolol and chlorthalidone]. Albertazzi A; Del Rosso G; Cappelli P G Clin Med; 1983; 64(3-4):124-30. PubMed ID: 6884639 [No Abstract] [Full Text] [Related]
49. [Intraerythrocytic potassium and diuretic therapy]. Otto GL; de Carvalho JG; Laffitte A; Baroni G Arq Bras Cardiol; 1989 Feb; 52(2):91-3. PubMed ID: 2596994 [TBL] [Abstract][Full Text] [Related]
50. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension. Angelino PF; Alvino-Demartino A; Mappa R; Donati C Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676 [TBL] [Abstract][Full Text] [Related]
51. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers. Godbillon J; Gerardin A; John VA; Theobald W Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension. Matthews KA; Brenner MJ; Brenner AC Clin Ther; 2013 Sep; 35(9):1423-30. PubMed ID: 23993697 [TBL] [Abstract][Full Text] [Related]
53. [Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril]. De Cesaris R; Ranieri G; Chiarappa R; Balestrazzi M; Antoncecchi E Clin Ter; 1986 Mar; 116(6):465-71. PubMed ID: 3522061 [No Abstract] [Full Text] [Related]
54. Diuretic-induced hypokalemia and altered renal function. Carney SL; Morgan TO Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):665-7. PubMed ID: 3546168 [TBL] [Abstract][Full Text] [Related]
55. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension. Bagatin J; Sardelić S; Pivac N; Polić S; Ljutic D; Rakic D; Naranca M; Bojić L; Kovacić Z; Rumboldt Z Int J Clin Pharmacol Res; 1998; 18(2):73-8. PubMed ID: 9675624 [TBL] [Abstract][Full Text] [Related]
56. Biochemical changes in black and Indian hypertensive patients on diuretic therapy. Bhigjee AI; Seedat YK; Hoosen S; Neerahoo RM; Naidoo K S Afr Med J; 1983 Dec; 64(25):969-72. PubMed ID: 6648735 [TBL] [Abstract][Full Text] [Related]
57. [Evaluation of the antihypertensive effectiveness of the combination of metoprolol and chlorthalidone, using the ergometric test]. Matteoli S; De Martino A; Filabozzi P; Greco V; Manzi M; Simonetti BM; Cinotti GA; Stirati G Boll Soc Ital Cardiol; 1981; 26(10):1207-11. PubMed ID: 7349142 [No Abstract] [Full Text] [Related]
58. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism. Ozbilen S; Eren MA; Turan MN; Sabuncu T Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552 [TBL] [Abstract][Full Text] [Related]
60. Effect of long-term treatment with celiprolol on pulmonary function in a group of mild hypertensive asthmatics. Clauzel AM; Jean T; Etienne R; Visier S; Michel F J Int Med Res; 1988; 16 Suppl 1():27A-33A. PubMed ID: 2975610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]